Group One Trading, L.P. Sc Pharmaceuticals Inc. Transaction History
Group One Trading, L.P.
- $2.68 Billion
- Q2 2025
A detailed history of Group One Trading, L.P. transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 20,962 shares of SCPH stock, worth $118,854. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,962
Previous 75,474
72.23%
Holding current value
$118,854
Previous $198,000
60.1%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding SCPH
# of Institutions
100Shares Held
37.8MCall Options Held
757KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA6.06MShares$34.4 Million0.82% of portfolio
-
Rubric Capital Management LP New York, NY4.6MShares$26.1 Million0.4% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.87MShares$21.9 Million8.33% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX3.54MShares$20.1 Million0.06% of portfolio
-
Morgan Stanley New York, NY2.15MShares$12.2 Million0.0% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $155M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...